FDA Approved: JADENU — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for JADENU (deferasirox) by Novartis Pharmaceuticals Corporation to expand its labeling for iron chelation in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload

Drugs mentioned

• JADENU (deferasirox)

Snippet

SUPPL AP for JADENU (DEFERASIROX)